Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by thadeushon Jan 14, 2017 9:28pm

245 Views

Post# 25709200

RE:Trial halted on remarkable results. Replaced placebo by drug

Bencro, as I may have mentioned before, that may be one of TLT's challenges: that big pharma won't have an expensive drug/process for them to make their ridiculous profits with. Even though I'm sure big pharma has only the patients' best interest in mind (*cough*), they will likely buy into the products that make them the most profit. TLT will have to bolster their bottom line somehow.

Bullboard Posts

A junior copper-gold stock trading at a bargain of monumental proportions